Intratumoral CXCR5+CD8+T Associates with Favorable Clinical Outcomes and Immunogenic Contexture in Gastric Cancer.

Jieti Wang,Ruochen Li,Yifan Cao,Yun Gu,Hanji Fang,Yuchao Fei,Kunpeng Lv,Xudong He,Chao Lin,Hao Liu,Heng Zhang,He Li,Hongyong He,Jiejie Xu,Hua Huang

DOI: https://doi.org/10.1038/s41467-021-23356-w

IF: 16.6

2021-01-01

Nature Communications

Abstract:Studies that examined an association between CD8 + T and prognosis in gastric cancer are inconsistent, and a distinct population of CXCR5 + CD8 + T associated with better overall survival has been reported among various malignancies. Here, we show that the abundance of intratumoral CXCR5 + CD8 + T cells is associated with better overall survival in patients with gastric cancer. Patients with TNM II + III gastric cancer with higher intratumoral CXCR5 + CD8 + T cell infiltration are more likely to benefit from adjuvant chemotherapy. Microsatellite-unstable and Epstein–Barr virus positive tumors are enriched with CXCR5 + CD8 + T cells. Gastric cancer infiltrating CXCR5 + CD8 + T cells represent a specific subtype of stem-like CD8 + T with effector memory feature. Identification of the clinical significance and phenotype of gastric cancer infiltrating CXCR5 + CD8 + T provides a roadmap for patient stratification and trials of targeted therapies.